Literature DB >> 19626465

Currents concepts on the immunopathology of amyloidosis.

Anupama Bhat1, Carlo Selmi, Stanley M Naguwa, Gurtej S Cheema, M Eric Gershwin.   

Abstract

Amyloidosis is defined as the extracellular accumulation at systemic or organ-specific level of insoluble low molecular weight protein fibrils manifesting a beta pleated sheet configuration and a characteristic staining pattern. Several different types of proteins may lead to this phenomenon, and amyloidosis is defined by the biochemical nature of the protein in the deposits and further classified according to whether the deposits are localized or systemic, acquired or inherited, and by the resulting clinical phenotype. Amyloidosis includes subtypes such as light chain, associated with serum amyloid A protein, heritable and familial forms, dialysis-related disease, and organ-specific conditions. The pathogenesis and clinical features of these clinical and pathological entities will be critically discussed in this review article.

Entities:  

Mesh:

Year:  2010        PMID: 19626465     DOI: 10.1007/s12016-009-8163-9

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN: 1080-0549            Impact factor:   8.667


  88 in total

1.  High prevalence of amyloid in 150 surgically removed heart valves--a comparison of histological and clinical data reveals a correlation to atheroinflammatory conditions.

Authors:  Arnt V Kristen; Philipp A Schnabel; Bettina Winter; Burkhard M Helmke; Thomas Longerich; Stefan Hardt; Achim Koch; Falk-Udo Sack; Hugo A Katus; Reinhold P Linke; Thomas J Dengler
Journal:  Cardiovasc Pathol       Date:  2009-06-06       Impact factor: 2.185

2.  Acute-phase response protein serum amyloid A stimulates renal tubule formation: studies in vitro and in vivo.

Authors:  Katherine J Kelly; Barbara Kluve-Beckerman; Jesus H Dominguez
Journal:  Am J Physiol Renal Physiol       Date:  2009-03-25

3.  Current clinical aspects of dialysis-related amyloidosis in chronic dialysis patients.

Authors:  Akihiko Saito; Fumitake Gejyo
Journal:  Ther Apher Dial       Date:  2006-08       Impact factor: 1.762

4.  Familial and primary (AL) cardiac amyloidosis: echocardiographically similar diseases with distinctly different clinical outcomes.

Authors:  S W Dubrey; K Cha; M Skinner; M LaValley; R H Falk
Journal:  Heart       Date:  1997-07       Impact factor: 5.994

5.  Systemic and microvascular oxidative stress induced by light chain amyloidosis.

Authors:  Raymond Q Migrino; Parameswaran Hari; David D Gutterman; Megan Bright; Seth Truran; Brittany Schlundt; Shane A Phillips
Journal:  Int J Cardiol       Date:  2009-05-15       Impact factor: 4.164

6.  Amyloidosis in juvenile chronic arthritis: a morbidity and mortality study.

Authors:  J David; O Vouyiouka; B M Ansell; A Hall; P Woo
Journal:  Clin Exp Rheumatol       Date:  1993 Jan-Feb       Impact factor: 4.473

7.  Clinical and histopathological features of progressive-type familial amyloidotic polyneuropathy with TTR Lys54.

Authors:  Takamura Nagasaka; Shinji Togashi; Harue Watanabe; Haruyasu Iida; Kaori Nagasaka; Yuki Nakamura; Michiaki Miwa; Fumikazu Kobayashi; Kazumasa Shindo; Zenji Shiozawa
Journal:  J Neurol Sci       Date:  2008-10-18       Impact factor: 3.181

8.  Interaction between circulating amyloid fibril protein precursors and extracellular tissue matrix components in the pathogenesis of systemic amyloidosis.

Authors:  G Husby; T Stenstad; J H Magnus; K Sletten; B Y Nordvåg; G Marhaug
Journal:  Clin Immunol Immunopathol       Date:  1994-01

9.  Amyloid fibril composition is related to the phenotype of hereditary transthyretin V30M amyloidosis.

Authors:  E Ihse; A Ybo; Ob Suhr; P Lindqvist; C Backman; P Westermark
Journal:  J Pathol       Date:  2008-10       Impact factor: 7.996

10.  Role of conformational change in the C-terminus of beta2-microglobulin in dialysis-related amyloidosis.

Authors:  Jaemi Kim; Yoshihiro Motomiya; Mitsuharu Ueda; Masaaki Nakamura; Yohei Misumi; Shiori Saito; Shinji Ikemizu; Shogo Misumi; Kazutoshi Ota; Satoru Shinriki; Hirofumi Kai; Yukio Ando
Journal:  Ann Clin Biochem       Date:  2008-09       Impact factor: 2.057

View more
  14 in total

1.  Abdominal distension and diarrhea as the main symptoms of primary amyloidosis: A case report and literature review.

Authors:  Jian Zhang; Chuxiao Shao; Jinde Zhu; Chaoyong Tu; Xinliang Lv
Journal:  Exp Ther Med       Date:  2016-02-19       Impact factor: 2.447

2.  The future of autoimmunity.

Authors:  Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2012-04       Impact factor: 8.667

3.  Mechanisms and pathophysiology of autoimmune disease.

Authors:  Wesley H Brooks
Journal:  Clin Rev Allergy Immunol       Date:  2012-02       Impact factor: 8.667

4.  Localized thymic amyloidosis presenting with myasthenia gravis: case report.

Authors:  Seung-Myoung Son; Yong-Moon Lee; Si Wook Kim; Ok-Jun Lee
Journal:  J Korean Med Sci       Date:  2013-12-26       Impact factor: 2.153

5.  Undiagnosed light chain systemic amyloidosis: does it matter to anesthesiologists? -a case report-.

Authors:  Gwan Ho Kim; Woo Kyung Lee; Se Hee Na; Jong Seok Lee
Journal:  Korean J Anesthesiol       Date:  2013-11-29

Review 6.  Small bowel amyloidosis.

Authors:  Milena Gould; Neda Zarrin-Khameh; Joseph Sellin
Journal:  Curr Gastroenterol Rep       Date:  2013-10

7.  Clinical outcomes and prognostic factors in patients with multiple myeloma in South Tyrol: a retrospective single-center analysis.

Authors:  Maximilian Mair; Christian Straka; Thomas Buratti; Martina Tauber; Manfred Mitterer; Dominic Fong
Journal:  Ann Hematol       Date:  2020-03-05       Impact factor: 3.673

8.  Structural mechanism of serum amyloid A-mediated inflammatory amyloidosis.

Authors:  Jinghua Lu; Yadong Yu; Iowis Zhu; Yifan Cheng; Peter D Sun
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-24       Impact factor: 11.205

Review 9.  Light chain (AL) amyloidosis: update on diagnosis and management.

Authors:  Michael Rosenzweig; Heather Landau
Journal:  J Hematol Oncol       Date:  2011-11-18       Impact factor: 17.388

10.  Association of skin with the pathogenesis and treatment of neurodegenerative amyloidosis.

Authors:  Audra L Clos; Rakez Kayed; Cristian A Lasagna-Reeves
Journal:  Front Neurol       Date:  2012-01-20       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.